ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Commonly Used Medical Questionnaires Can Only Predict Half of Men with Low T
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 7472" data-attributes="member: 3"><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24739016#" target="_blank">Aging Male.</a> 2014 Apr 16. [Epub ahead of print]</p><p><strong></strong></p><p><strong>Performance of Massachusetts Male Aging Study (MMAS) and androgen deficiency in the aging male (ADAM) questionnaires in the prediction of free testosterone in patients aged 40 years or older treated in outpatient regimen.</strong></p><p></p><p></p><p><strong>Abstract</strong></p><p></p><p>Objective: At present, calculated free testosterone assessment is considered as the gold standard in diagnosing male hypogonadism. However, this assessment is not available for all the individuals diagnosed with decreased testicular function. </p><p></p><p>The investigators of this study were, thus, prompted to evaluate whether the androgen deficiency in the aging male (ADAM) and the Massachusetts Male Ageing Study (MMAS) questionnaires could be used to replace biochemical parameters in the diagnosis for hypogonadism in men aged 40 years and above. </p><p></p><p>Methods: We evaluated 460 men, aged 40 years and above, all volunteers of a screening program for prostate cancer based at the Hospital de Clínicas of Porto Alegre. In this study, we assessed the efficiency of the ADAM and MMAS questionnaires in diagnosing Brazilian men with low levels of total, calculated free and bioavailable testosterone. </p><p></p><p>Results: The sensitivity of the ADAM questionnaire in diagnosing the calculated free testosterone was 73.6%, whereas specificity was 31.9%. ADAM could be used to properly classify our cohort into normal or hypogonadal individuals in <strong>52.75% of the cases.</strong> The sensitivity of the MMAS questionnaire was 59.9%, whereas the specificity was 42.9%, resulting in a successful classification of <strong>51.4% of the patients</strong>. Conclusion: The ADAM and MMAS questionnaires showed adequate sensitivity in diagnosing male patients with low levels of free testosterone.<strong> However, because of the lack of specificity, these tools cannot replace calculated free testosterone assessments in men aged 40 years and above.</strong></p><p><strong></strong></p><p><strong>More on ADAM: </strong><a href="https://www.excelmale.com/forum/threads/405-How-do-you-know-if-you-need-testosterone-replacement?highlight=adam" target="_blank">https://www.excelmale.com/forum/threads/405-How-do-you-know-if-you-need-testosterone-replacement?highlight=adam</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 7472, member: 3"] [URL="http://www.ncbi.nlm.nih.gov/pubmed/24739016#"]Aging Male.[/URL] 2014 Apr 16. [Epub ahead of print] [B] Performance of Massachusetts Male Aging Study (MMAS) and androgen deficiency in the aging male (ADAM) questionnaires in the prediction of free testosterone in patients aged 40 years or older treated in outpatient regimen.[/B] [B]Abstract[/B] Objective: At present, calculated free testosterone assessment is considered as the gold standard in diagnosing male hypogonadism. However, this assessment is not available for all the individuals diagnosed with decreased testicular function. The investigators of this study were, thus, prompted to evaluate whether the androgen deficiency in the aging male (ADAM) and the Massachusetts Male Ageing Study (MMAS) questionnaires could be used to replace biochemical parameters in the diagnosis for hypogonadism in men aged 40 years and above. Methods: We evaluated 460 men, aged 40 years and above, all volunteers of a screening program for prostate cancer based at the Hospital de Clínicas of Porto Alegre. In this study, we assessed the efficiency of the ADAM and MMAS questionnaires in diagnosing Brazilian men with low levels of total, calculated free and bioavailable testosterone. Results: The sensitivity of the ADAM questionnaire in diagnosing the calculated free testosterone was 73.6%, whereas specificity was 31.9%. ADAM could be used to properly classify our cohort into normal or hypogonadal individuals in [B]52.75% of the cases.[/B] The sensitivity of the MMAS questionnaire was 59.9%, whereas the specificity was 42.9%, resulting in a successful classification of [B]51.4% of the patients[/B]. Conclusion: The ADAM and MMAS questionnaires showed adequate sensitivity in diagnosing male patients with low levels of free testosterone.[B] However, because of the lack of specificity, these tools cannot replace calculated free testosterone assessments in men aged 40 years and above. More on ADAM: [/B][URL]https://www.excelmale.com/forum/threads/405-How-do-you-know-if-you-need-testosterone-replacement?highlight=adam[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Commonly Used Medical Questionnaires Can Only Predict Half of Men with Low T
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top